{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T17:28:17Z","timestamp":1749576497037},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","interventional.theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Interventional Cardiology Clinics"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.iccl.2017.03.013","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T01:17:30Z","timestamp":1493255850000},"page":"453-464","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Renal Denervation to Modify Hypertension and the Heart Failure State"],"prefix":"10.1016","volume":"6","author":[{"given":"Ming","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke K.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh V.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitriy N.","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iccl.2017.03.013_bib1","doi-asserted-by":"crossref","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"117","author":"Calhoun","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib2","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1161\/CIRCULATIONAHA.112.097345","article-title":"Resistant hypertension: incidence, prevalence and prognosis","volume":"125","author":"Pimenta","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrneph.2012.260","article-title":"Resistant hypertension\u2013its identification and epidemiology","volume":"9","author":"Sarafidis","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.iccl.2017.03.013_bib4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1161\/CIRCULATIONAHA.111.068064","article-title":"Incidence and prognosis of resistant hypertension in\u00a0hypertensive patients","volume":"125","author":"Daugherty","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1161\/CIRCINTERVENTIONS.112.000037","article-title":"Renal sympathetic denervation therapy for resistant hypertension: a contemporary synopsis and future implications","volume":"6","author":"Myat","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"issue":"4","key":"10.1016\/j.iccl.2017.03.013_bib6","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4330\/wjc.v5.i4.94","article-title":"Renal sympathetic denervation in resistant hypertension","volume":"5","author":"Santos","year":"2013","journal-title":"World J Cardiol"},{"key":"10.1016\/j.iccl.2017.03.013_bib7","first-page":"611","article-title":"The sympathetic nervous system through the ages: from Thomas Willis to resistant hypertension","volume":"96","author":"Esler","year":"2011","journal-title":"Exp Physiol"},{"issue":"1","key":"10.1016\/j.iccl.2017.03.013_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1161\/01.HYP.11.1.3","article-title":"Assessment of the human sympathetic nervous system activity from measurements of norepinephrine turnover","volume":"11","author":"Esler","year":"1988","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/j.iccl.2017.03.013_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0895-7061(02)02959-X","article-title":"Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity","volume":"15","author":"Ye","year":"2002","journal-title":"Am J Hypertens"},{"issue":"1","key":"10.1016\/j.iccl.2017.03.013_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1093\/ajh\/3.1.62","article-title":"Renal denervation decreases blood pressure in DOCA-treated miniature swine with established hypertension","volume":"3","author":"O\u2019Hagan","year":"1990","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.iccl.2017.03.013_bib11","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.HYP.25.4.893","article-title":"Renal denervation attenuates the sodium retention and hypertension associated with obesity","volume":"25","author":"Kassab","year":"1995","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.iccl.2017.03.013_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI100652","article-title":"The effect of renal denervation on the level of arterial blood pressure and renal function in essential hypertension","volume":"14","author":"Page","year":"1935","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.iccl.2017.03.013_bib13","first-page":"1501","article-title":"Splanchnicectomy for essential hypertension; results in 1,266 cases","volume":"152","author":"Smithwick","year":"1953","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.iccl.2017.03.013_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/01.CIR.4.2.173","article-title":"The effects of splanchnicectomy on the blood pressure in hypertension: a controlled study","volume":"4","author":"Hoobler","year":"1951","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.iccl.2017.03.013_bib15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s12170-013-0334-9","article-title":"Novel approaches for the treatment of the patient with resistant hypertension: renal nerve ablation","volume":"7","author":"Gulati","year":"2013","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"5","key":"10.1016\/j.iccl.2017.03.013_bib16","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.110.163014","article-title":"Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months","volume":"57","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/j.iccl.2017.03.013_bib17","doi-asserted-by":"crossref","first-page":"E1386","DOI":"10.1016\/S0735-1097(13)61386-8","article-title":"Renal sympathetic denervation for treatment of resistant hypertension: two-year update from the SYMPLICITY HTN-2 randomized controlled trial","volume":"61","author":"Esler","year":"2013","journal-title":"J\u00a0Am Coll Cadiol"},{"key":"10.1016\/j.iccl.2017.03.013_bib18","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A\u00a0controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9981","key":"10.1016\/j.iccl.2017.03.013_bib19","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardized antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicenter, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.iccl.2017.03.013_bib20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCRESAHA.115.304099","article-title":"Renal denervation and SYMPLICITY HTN-3: \u201cDubium sapientiae initium\u201d (doubt is the beginning of wisdom)","volume":"115","author":"Papademetriou","year":"2014","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.iccl.2017.03.013_bib21","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/nrcardio.2014.70","article-title":"Hypertension: how should data from SYMPLICITY HTN-3 be interpreted?","volume":"11","author":"Schmider","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"18","key":"10.1016\/j.iccl.2017.03.013_bib22","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2015.02.038","article-title":"Treatment of hypertension in patients with coronary artery disease. A scientific statement from the American Heart Association, American College of Cardiology, and American Society of Hypertension","volume":"65","author":"Rosendorff","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.iccl.2017.03.013_bib23","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ahj.2015.08.021","article-title":"The SPYRAL HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications","volume":"171","author":"Kandzari","year":"2016","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.iccl.2017.03.013_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1161\/01.CIR.73.4.615","article-title":"Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity","volume":"73","author":"Hasking","year":"1986","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.iccl.2017.03.013_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11886-012-0258-x","article-title":"The role of renal denervation in the treatment of heart failure","volume":"14","author":"Sobotka","year":"2012","journal-title":"Curr Cardiol Rep"},{"issue":"19","key":"10.1016\/j.iccl.2017.03.013_bib26","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2009.05.015","article-title":"The sympathetic nervous system in heart failure: physiology, pathophysiology, and clinical implications","volume":"54","author":"Triposkiadis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.iccl.2017.03.013_bib27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1161\/01.CIR.82.5.1724","article-title":"Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the studies of left ventricular dysfunction (SOLVD)","volume":"82","author":"Francis","year":"1990","journal-title":"Circulation"},{"issue":"13","key":"10.1016\/j.iccl.2017.03.013_bib28","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJM198409273111303","article-title":"Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure","volume":"311","author":"Cohn","year":"1984","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iccl.2017.03.013_bib29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1161\/01.CIR.94.4.690","article-title":"Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction: SOLVD investigators","volume":"94","author":"Benedict","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib30","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/eurheartj\/ehi184","article-title":"Long-term outcome in relation to renal sympathetic activity in patients with chronic heart failure","volume":"26","author":"Petersson","year":"2005","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.iccl.2017.03.013_bib31","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2017.03.013_bib32","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1445-5994.1999.tb00737.x","article-title":"Sympathetic activation and the role of beta-blockers in chronic heart failure","volume":"29","author":"Krum","year":"1999","journal-title":"Aust N Z J Med"},{"key":"10.1016\/j.iccl.2017.03.013_bib33","first-page":"VI40","article-title":"Plasma norepinephrine, plasma renin activity, and congestive heart failure. Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA cooperative studies group","volume":"87","author":"Francis","year":"1993","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.iccl.2017.03.013_bib34","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMc0904179","article-title":"Renal sympathetic nerve ablation for uncontrolled hypertension","volume":"361","author":"Schlaich","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iccl.2017.03.013_bib35","first-page":"38","article-title":"Role of the renal nerves in sodium retention and edema formation","volume":"101","author":"DiBona","year":"1990","journal-title":"Trans AM Clin Climatol Assoc"},{"issue":"9","key":"10.1016\/j.iccl.2017.03.013_bib36","doi-asserted-by":"crossref","first-page":"e45986","DOI":"10.1371\/journal.pone.0045986","article-title":"Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.iccl.2017.03.013_bib37","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1590\/S0100-879X2004000200017","article-title":"Chronic experimental myocardial infarction produces antinatriuresis by a renal nerve-dependent mechanism","volume":"37","author":"Souza","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"5 Pt 2","key":"10.1016\/j.iccl.2017.03.013_bib38","first-page":"R1599","article-title":"Effects of renal denervation on postprandial sodium excretion in experimental heart failure","volume":"266","author":"Villarreal","year":"1994","journal-title":"Am J Physiol"},{"issue":"1","key":"10.1016\/j.iccl.2017.03.013_bib39","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00088.2010","article-title":"Renal denervation modulates angiotensin receptor expression in the renal cortex of rabbits with chronic heart failure","volume":"300","author":"Clayton","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.iccl.2017.03.013_bib40","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.cardfail.2011.06.652","article-title":"Activity with ambulation attenuates diuretic responsiveness in chronic heart failure","volume":"17","author":"Galiwango","year":"2011","journal-title":"J\u00a0Card Fail"},{"issue":"3","key":"10.1016\/j.iccl.2017.03.013_bib41","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2012.09.019","article-title":"First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study","volume":"162","author":"Davies","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.iccl.2017.03.013_bib42","doi-asserted-by":"crossref","first-page":"A10452","DOI":"10.1161\/circ.132.suppl_3.10452","article-title":"The SYMPLICITY HF feasibility study: twelve month outcomes of renal denervation in patients with chronic heart failure and renal impairment","volume":"132","author":"Krum","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib43","unstructured":"Taborsky M. Renal denervation in patients with\u00a0heart failure and severe left ventricular dysfunction. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01870310. NLM Identifier: NCT01870310. Accessed October 25, 2016."},{"key":"10.1016\/j.iccl.2017.03.013_bib44","unstructured":"Hernandez A. Study of renal denervation in patients with heart failure (PRESERVE). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US); 2000. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01954160. NLM Identifier: NCT01954160. Accessed October 25, 2016."},{"key":"10.1016\/j.iccl.2017.03.013_bib45","unstructured":"Davies J. Renal artery denervation in chronic heart failure study (REACH). In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). 2000. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01639378. NLM Identifier: NCT01639378. Accessed October 25, 2016."},{"key":"10.1016\/j.iccl.2017.03.013_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.111.00182","article-title":"Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation","volume":"61","author":"Linz","year":"2013","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.iccl.2017.03.013_bib47","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.hrthm.2013.07.015","article-title":"Renal denervation suppresses ventricular arrhythmias during acute ventricular ischemia in pigs","volume":"10","author":"Linz","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.iccl.2017.03.013_bib48","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.109.138610","article-title":"Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept","volume":"54","author":"Schlaich","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.iccl.2017.03.013_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1161\/HYPERTENSIONAHA.108.121467","article-title":"Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction","volume":"53","author":"Grassi","year":"2009","journal-title":"Hypertension"},{"issue":"3","key":"10.1016\/j.iccl.2017.03.013_bib50","doi-asserted-by":"crossref","first-page":"e0149855","DOI":"10.1371\/journal.pone.0149855","article-title":"Impact of renal denervation on left ventricular structure and function at 1-year follow-up","volume":"11","author":"De Sousa Almeida","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.iccl.2017.03.013_bib51","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.jacc.2011.11.034","article-title":"Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension","volume":"59","author":"Brandt","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"18","key":"10.1016\/j.iccl.2017.03.013_bib52","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.jacc.2013.10.073","article-title":"Improvements in left ventricular hypertrophy and diastolic function following denervation: effects beyond blood pressure and heart rate reduction","volume":"63","author":"Schirmer","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.iccl.2017.03.013_bib53","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/ejhf.502","article-title":"Renal denervation in heart failure with preserved ejection fraction (RDT-PEF): a randomized controlled trial","volume":"18","author":"Patel","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"12","key":"10.1016\/j.iccl.2017.03.013_bib54","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/eurjhf\/hft119","article-title":"Renal denervation in heart failure with normal left ventricular ejection fraction. Rationale and design of the DIASTOLE (Denervation of the Renal Sympathetic Nerves in Heart Failure with Normal LV Ejection Fraction) trial","volume":"15","author":"Verloop","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.iccl.2017.03.013_bib55","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1161\/01.CIR.0000129252.96341.8B","article-title":"Sympathetic drive in anterior and inferior uncomplicated acute myocardial infarction","volume":"109","author":"Graham","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib56","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJM199212313272704","article-title":"Sympathetic overactivity in patients with chronic renal failure","volume":"327","author":"Converse","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.iccl.2017.03.013_bib57","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/jce.12553","article-title":"Renal denervation for treatment of cardiac arrhythmias: state of the art and future directions","volume":"26","author":"Kosiuk","year":"2015","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"issue":"18","key":"10.1016\/j.iccl.2017.03.013_bib58","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1161\/CIRCULATIONAHA.110.991869","article-title":"Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study","volume":"123","author":"Mahfoud","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.iccl.2017.03.013_bib59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1161\/HYPERTENSIONAHA.111.173799","article-title":"Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea","volume":"58","author":"Witkowski","year":"2011","journal-title":"Hypertension"}],"container-title":["Interventional Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211745817300445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T20:14:37Z","timestamp":1719173677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211745817300445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2211745817300445"],"URL":"https:\/\/doi.org\/10.1016\/j.iccl.2017.03.013","relation":{},"ISSN":["2211-7458"],"issn-type":[{"value":"2211-7458","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Renal Denervation to Modify Hypertension and the Heart Failure State","name":"articletitle","label":"Article Title"},{"value":"Interventional Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iccl.2017.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}